AzTrials
AzTrials

Trauma (Including Fractures)MTTSSNCT07582263

MOTORCYCLE THORACIC TRAUMA SEVERITY SCORE: A NEW TRAUMA SEVERITY SCORE

An observational study of Trauma (Including Fractures) and Trauma Centers, run by Antalya Health Sciences University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to test the hypothesis that a practical, bedside-applicable tool could be developed to help identify patients at high risk of mortality following motorcycle accidents more quickly and facilitate treatment by enabling faster clinical decision-making. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Training set and Test set
How many people
1,000 participants
Where
1 siteTurkey (Türkiye)
Study dates
6 May 2026to 10 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study planned to include patients aged 18 years and over who had been involved in a motorcycle accident (as a rider or passenger) and had a chest injury that had been radiologically or clinically confirmed, as well as patients whose medical records had been fully documented during the chart review.

Who may be able to join

  • patients aged 18 years or over
  • motorcycle accident (a rider or a passenger)
  • radiologically or clinically confirmed chest injury
  • fully documented in the medical records.

Who cannot join

  • penetrating chest trauma
  • patients under the age of 18
  • isolated non-chest trauma
  • incomplete documentation

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • University of Health Sciences, Antalya Training and Research Hospital

    Antalya

Other trials in Turkey (Türkiye)

About this study

Official title: MOTORCYCLE THORACIC TRAUMA SEVERITY SCORE DEVELOPMENT AND VALIDATION OF A NOVEL PREDICTIVE TOOL FOR MORTALITY AND PULMONARY COMPLICATIONS

This study aimed to test the hypothesis that a practical, bedside-applicable tool could be developed to help identify patients at high risk of mortality following motorcycle accidents more quickly and facilitate treatment by enabling faster clinical decision-making.

Read the detailed description

Injuries resulting from motorcycle accidents are one of the leading causes of death worldwide, and rates are increasing. This increase is attributed to the disproportionate vulnerability of riders at the moment of impact, inadequate protective barriers during collisions, motorcycles' ability to reach high speeds and biomechanical exposure. The thoracic cage is the anatomical region most commonly affected in motorcycle accident-related injuries. This study aimed to test the hypothesis that a practical, bedside-applicable tool could be developed to help identify patients at high risk of mortality following motorcycle accidents more quickly and facilitate treatment by enabling faster clinical decision-making.

Being tested
Training set, Test set
Keywords
motorsycle, thorax, trauma, severity score, mortality
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training setOther

    Training set for model development

  • Test setOther

    Independent test set for validation

Study groups in NCT07582263
Study groupRoleWhat they receive
Training setNot described
Receives: Other: Training set
Test setNot described
Receives: Other: Test set

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In-hospital mortality

    Measured: 30 days after ICU admission

Secondary outcomes (4)
  1. Develop and validate the model

    Measured: 30 days after ICU admission

  2. Assess the model's discriminatory performance, calibration and classification accuracy

    Measured: 30 days after ICU admission

  3. Classify patients into clinically meaningful risk categories

    Measured: 30 days after ICU admission

  4. Assess the independent contribution of helmet use and chest injury patterns to mortality prediction

    Measured: 30 days after ICU admission

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2026
  2. Study start6 May 2026
  3. Primary completion3 Jun 2026
  4. Study completion10 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
1,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07582263
Sponsor's protocol ID
11/10
Acronym
MTTSS
Status last verified
May 2026
First submitted
6 May 2026
Last updated
16 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lavoie A, Moore L, LeSage N, Liberman M, Sampalis JS. The New Injury Severity Score: a more accurate predictor of in-hospital mortality than the Injury Severity Score. J Trauma. 2004 Jun;56(6):1312-20. doi: 10.1097/01.ta.0000075342.36072.ef.

    PubMed 15211142
  • Schluter PJ. Trauma and Injury Severity Score (TRISS): is it time for variable re-categorisations and re-characterisations? Injury. 2011 Jan;42(1):83-9. doi: 10.1016/j.injury.2010.08.036.

    PubMed 20851396

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma (Including Fractures) and Trauma Centers, run by Antalya Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In-hospital mortality (time frame: 30 days after ICU admission). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07582263, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in